Health insurance in India does cover modern medical treatments such as robotic surgery, but the extent of that coverage is not uniform across insurers — and the list of treatments, sub-limits, and conditions attached to them can vary significantly from one policy to another.
What Counts as a “Modern Treatment” and What the Regulations Require
The claim settlement ratio of health insurance companies is published annually by IRDAI and gives buyers an objective, independently verified basis for comparing insurer reliability before committing to any policy. A consistently high claim settlement ratio of health insurance companies indicates that valid claims are routinely approved and paid without unnecessary disputes, while a low or volatile ratio is a warning sign of trouble at the worst possible time. Star Health performs strongly on the claim settlement ratio of health insurance companies, a reflection of its dedicated claims infrastructure and exclusive focus on health products. When studying the claim settlement ratio of health insurance companies, examine three to five years of data rather than a single standout year, and consider settlement speed alongside the headline percentage. Making the claim settlement ratio of health insurance companies a core filter in your shortlisting process is one of the simplest habits that separates informed buyers from those who discover problems only at claim time.
Today, many health insurance plans in India provide coverage for modern medical treatments and advanced healthcare procedures, and the policies that include this benefit normally extend it to in-patient hospitalisation, domiciliary treatment, day-care treatment, and pre- and post-hospitalisation costs connected to the procedure — not just the surgery or therapy session itself in isolation.
In 2019, the Insurance Regulatory and Development Authority of India (IRDAI) mandated that all health insurance companies cover 12 specific advanced treatment procedures under what is called the “Modern Treatment Benefit.” This list includes:
Uterine Artery Embolisation and HIFU (High Intensity Focused Ultrasound)
Balloon Sinuplasty
Deep Brain Stimulation
Oral Chemotherapy
Anti-immune therapy (Monoclonal Antibody injected)
Intra-vitreal Injections
Robotic Surgeries
Stereotactic Radiosurgeries
Bronchial Thermoplasty
Vaporisation of the Prostate
IONM (Intra Operative Neuro Monitoring)
Stem Cell Therapy for Bone Marrow Transplant in Haematological Conditions
Insurers may label this benefit differently — some call it “Modern Treatment Benefits,” others “coverage for Technological Advancements and Treatments” — but the underlying list of procedures, per IRDAI guidelines, should largely overlap. Coverage under this benefit typically extends beyond the procedure itself to related expenses such as hospitalisation, pre- and post-treatment care, and day-care procedures when applicable. Importantly, while the regulator’s mandate sets a floor that every insurer must meet, it does not standardise how generously each insurer pays out — so two policies that both technically “cover” all 12 procedures can still leave a policyholder with very different out-of-pocket bills depending on the sub-limits, exclusions, and wording each insurer attaches to the same list.
Even though coverage of these 12 treatments is mandatory, that does not guarantee full reimbursement. Many insurers impose sub-limits on these procedures — some policies cap reimbursement for treatments like robotic surgery or stem cell therapy at a fraction of the sum insured, anywhere from roughly 25-50% of the total cover to a much tighter cap of around 1% in some policies, meaning only a small portion of an expensive procedure’s actual cost gets reimbursed even though the treatment itself is technically “covered.” To put that in concrete terms: if a policy carries a 1% sub-limit on robotic surgery and the sum insured is ₹10 lakh, only up to ₹1 lakh of the robotic-surgery cost may be paid out, regardless of what the hospital actually bills — the policyholder is responsible for the rest. Some insurers apply “traditional cost clauses,” reimbursing only what an equivalent conventional (non-robotic) surgery would have cost, leaving the policyholder to pay the difference between that and the actual robotic-surgery bill. Coverage can also depend on the surgery being performed by a properly trained and qualified robotic surgeon, and insurers may require advance pre-authorisation before the procedure is scheduled. A waiting period of about 30 days applies to all health insurance claims generally, and pre-existing conditions can carry a waiting period of one to four years depending on the insurer and plan — so a person who needs deep brain stimulation or stem cell therapy for a condition diagnosed before the policy was bought may need to wait considerably longer than someone using the benefit for a newly diagnosed issue. Sub-limits of this kind are not unique to robotic surgery either — they commonly apply across the same list to other costly modern procedures such as immunotherapy, stem cell therapy, and stereotactic radiosurgery, so it is worth checking the sub-limit attached to whichever specific procedure is relevant to you rather than assuming the policy’s overall sum insured is the real ceiling.
Before relying on modern-treatment coverage, check your policy documents for whether the benefit is capped or available up to the full sum insured, any co-payment clauses for advanced procedures, treatment-specific waiting periods, and pre-authorisation requirements. A written prescription from a qualified medical practitioner confirming medical necessity is mandatory — without it, insurers can reject the claim. It’s also worth noting that insurers are not required to use identical terminology: some label this the “Modern Treatment Benefit,” others call it “coverage for Technological Advancements and Treatments,” but the underlying list of 12 procedures should largely overlap across insurers because it derives from the same IRDAI mandate, even though the sub-limits attached to each procedure can differ sharply.
Coverage for Other Expensive Treatments
Beyond the IRDAI-mandated modern treatments, the broader cost of healthcare in India — for conditions like cancer, kidney disease, heart and lung disease, liver cirrhosis, and Alzheimer’s disease — continues to rise, making comprehensive insurance valuable for managing these expenses. Cancer treatment is typically singled out as the costliest category, given how doctor consultations, diagnostics, and ongoing treatment can run into the lakhs; heart-related diseases, kidney disease, and liver cirrhosis follow closely behind in terms of how quickly the bills can escalate. The same set of modern treatments named under the IRDAI list — oral chemotherapy, immunotherapy, intravitreal injections, stem cell therapy, stereotactic radiosurgery, robotic surgery, deep brain stimulation, uterine artery embolisation and HIFU, bronchial thermoplasty, and balloon sinuplasty — also doubles as a list of some of the costliest procedures a patient is likely to encounter, which is precisely why the sub-limits discussed above matter so much in practice. A good policy for expensive treatments typically offers an adequate sum insured (with the option of add-on covers), coverage for in-patient, pre- and post-hospitalisation, domiciliary hospitalisation, and day-care procedures, plus the ability to claim for both modern treatments and preventive health check-ups.
Other benefits worth looking for include no-claim bonuses and long-term discounts that reduce premiums over time, hospital cash for additional financial support, flexible premium payment options (monthly, quarterly, or half-yearly), and automatic restoration of the sum insured once it is exhausted, as per policy terms. Comprehensive plans for expensive treatments often also include room rent and ambulance cost coverage, surgery and vaccination expense coverage, a second medical opinion option, home care treatment costs as per policy terms, and unlimited medical consultation on digital platforms. Together, these features matter more for high-cost treatments than they do for routine hospitalisation, because the gap between what a sub-limited policy pays and what the actual bill comes to widens sharply as treatment costs rise into the lakhs.
The combination of an adequate sum insured with the option to add on supplementary covers is what ultimately determines whether a policyholder undergoing an expensive modern treatment is genuinely protected or merely partially protected. A broad range of coverage — spanning room rent, ambulance costs, surgery and vaccination expenses, a second medical opinion, home care treatment, and digital consultation access — is what relieves financial distress during an already stressful period, rather than any single feature working in isolation. Policyholders who treat no-claim bonuses, long-term discounts, and automatic restoration of sum insured as add-ons to actively ask about, rather than assuming they come bundled into every plan, tend to get noticeably better value when a genuinely expensive treatment does become necessary.
Whether you’re evaluating coverage for a robotic surgery or any other costly procedure, the underlying advice is the same: read the policy’s fine print carefully to understand sub-limits, co-payment clauses, and waiting periods, and check the insurer’s reputation and claim settlement track record before purchasing, so that the financial protection holds up when you actually need it. A policy that advertises “modern treatment coverage” prominently but caps reimbursement tightly is not necessarily a bad policy — it simply means you should budget for, or insure separately against, the gap between the cap and the real-world cost of the procedure you’re most likely to need. Browsing multiple plans side by side, reading the policy wording rather than just the brochure, and weighing the insurer’s track record on settling claims promptly are the same three steps that apply whether the expensive treatment in question is a single robotic surgery or an extended course of cancer therapy — the underlying goal in either case is making sure the financial protection promised on paper actually holds up at the point you need to use it.
Arranging health insurance for parents is among the most meaningful financial decisions an adult child can make, as ageing parents face higher hospitalisation rates, chronic condition management, and treatments that can run into several lakhs without warning. Dedicated health insurance for parents covers age-related conditions including cardiac ailments, diabetes complications, orthopaedic procedures, and kidney disorders, with pre-existing diseases included after the applicable waiting period. Star Health’s health insurance for parents offers realistic sum insured options, cashless access to hospitals equipped for geriatric care, and transparent terms without hidden sub-limits that erode coverage when it matters most. Buying health insurance for parents while they are still in reasonable health — ideally before 65 — secures lower premiums, fewer exclusions, and completed waiting periods before major claims become likely. If your family floater currently covers your parents, compare it against standalone health insurance for parents; the dedicated plan frequently delivers significantly better protection for older members.
